Key Drivers
- Strong Liquidity
- Thin Margins
- Cash Flow
AIAI Summary
ICUI has shifted from a simple recovery trade to a “prove-it” investment, where solid liquidity and free cash flow plus possible share gains offer downside support, but sustained upside now depends on visible revenue growth and margin expansion before interest expense, Smiths integration risk, and governance noise keep capping valuation.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Strong Liquidity
- •Thin Margins
- •Cash Flow
ICU Medical has a strong liquidity and cash-flow foundation, but weak profitability, meaningful intangibles, and interest drag keep the investment case cautious despite manageable leverage.
Price Behavior
Key Price Behavior Insights:
- •Strong momentum
- •Breakout hold
- •Stretch risk
ICUI remains technically constructive after an 18.8% uptrend and breakout above $148-$149, but the move is stretched and needs to hold $148/$142 support to avoid a pullback.
Fast rise from $142.95 to $154.97 in a week suggests short-term volatility and pullback risk
Sentiment & News
Key News Insights:
- •Smiths Integration
- •Insider Selling
- •Bullish Analyst Call
ICUI headlines were mixed, with insider selling and ongoing Smiths integration offset by a bullish analyst call and renewed value-focused interest.
The news suggests near-term uncertainty, but analyst optimism and valuation interest could support the stock if integration progress continues
Similar Companies in Healthcare
Other companies in the same sector with AI ratings